Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- SIERRAIndependent statistical analysis of A Study to Evaluate the Effects of Rituximab on Immune Responses in Subjects With Active Rheumatoid Arthritis Receiving Background Methotrexate: primary endpoint results, effect estimate with confidence interval,…
- SiFALDIndependent statistical analysis of Role of Sildenafil for Fontan Associated Liver Disease (SiFALD) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03154476).
- SIGMARTIndependent statistical analysis of Research on Nicorandil Treatment of Patients Diagnosed as CHD (Coronary Heart Disease) With Stable Angina: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- SIGNATUREIndependent statistical analysis of LDE225 for Patients With PTCH1 or SMO Mutated Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02002689).
- SIGNATUREIndependent statistical analysis of MEK162 for Patients With RAS/RAF/MEK Activated Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01885195).
- Sildenafil for Chronic Obstructive Pulmonary Disease: Complete Statistical AnalysisIndependent statistical analysis of Sildenafil for Chronic Obstructive Pulmonary Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00104637).
- Sildenafil for the Treatment of Lymphatic Malformations: Complete Statistical AnalysisIndependent statistical analysis of Sildenafil for the Treatment of Lymphatic Malformations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02335242).
- Sildenafil in HFpEF (Heart Failure With Preserved Ejection Fraction) and PH: Complete Statistical AnalysisIndependent statistical analysis of Sildenafil in HFpEF (Heart Failure With Preserved Ejection Fraction) and PH: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Sildenafil Treatment for Mild TBI: Complete Statistical AnalysisIndependent statistical analysis of Sildenafil Treatment for Mild TBI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03598140).
- Sildenafil Vaginal Gel Co-treatment With Clomiphene Citrate in Infertile Women With Thin Endometrium: Complete Statistical AnalysisIndependent statistical analysis of Sildenafil Vaginal Gel Co-treatment With Clomiphene Citrate in Infertile Women With Thin Endometrium: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Silicone Adhesive Multilayer Foam Dressings to Prevent Pressure Ulcer: Complete Statistical AnalysisIndependent statistical analysis of Silicone Adhesive Multilayer Foam Dressings to Prevent Pressure Ulcer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03442777).
- Silk’n HST Device Usability and Self Selection Study: Complete Statistical AnalysisIndependent statistical analysis of Silk'n HST Device Usability and Self Selection Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02919007).
- Siltuximab and Spartalizumab in Patients With Metastatic Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Siltuximab and Spartalizumab in Patients With Metastatic Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04191421).
- Silver Impregnated Dressings to Reduce Wound Complications in Obese Patients at Cesarean Section: Complete Statistical AnalysisIndependent statistical analysis of Silver Impregnated Dressings to Reduce Wound Complications in Obese Patients at Cesarean Section: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SIMCERIndependent statistical analysis of A National Multi-center Randomized, Open Label Study to Evaluate Efficacy and Safety of Everolimus With EC-MPS Compared to Standard Treatment Combination Tacrolimus and EC-MPS in de Novo Liver…
- Simplification From Tenofovir Plus Lamivudine or Emtricitabine Plus Ritonavir-Boosted-Protease Inhibitor to Ritonavir-Boosted-Atazanavir Plus Lamivudine in Virologically-Suppressed-HIVInfected Adults With Osteopenia: Complete Statistical AnalysisIndependent statistical analysis of Simplification From Tenofovir Plus Lamivudine or Emtricitabine Plus Ritonavir-Boosted-Protease Inhibitor to Ritonavir-Boosted-Atazanavir Plus Lamivudine in Virologically-Suppressed-HIVInfected Adults With Osteopenia: primary endpoint results, effect estimate with confidence interval, sample-size…
- Simplified Negative Pressure Wound Therapy: Complete Statistical AnalysisIndependent statistical analysis of Simplified Negative Pressure Wound Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01339429).
- Simplifying Treatment and Monitoring for HIV (STREAM HIV): Complete Statistical AnalysisIndependent statistical analysis of Simplifying Treatment and Monitoring for HIV (STREAM HIV): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04341779).
- SIMTIndependent statistical analysis of SIMT Stereotactic Radiosurgery Outcomes Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02886572).
- Simtuzumab (GS-6624) in the Prevention of Progression of Liver Fibrosis in Adults With Primary Sclerosing Cholangitis (PSC): Complete Statistical AnalysisIndependent statistical analysis of Simtuzumab (GS-6624) in the Prevention of Progression of Liver Fibrosis in Adults With Primary Sclerosing Cholangitis (PSC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Simulated Driving Performance, Daytime Sedation and Cognition in Healthy Volunteers Taking Gralise, Neurontin or Lyrica: Complete Statistical AnalysisIndependent statistical analysis of Simulated Driving Performance, Daytime Sedation and Cognition in Healthy Volunteers Taking Gralise, Neurontin or Lyrica: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Simultaneous Assessment of FFR and SPECT: Complete Statistical AnalysisIndependent statistical analysis of Simultaneous Assessment of FFR and SPECT: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02749045).
- SimVADIndependent statistical analysis of Use of Simulation to Improve VAD Self-management: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03073005).
- Simvastatin and Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ or Invasive Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Simvastatin and Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ or Invasive Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Single Agent Temsirolimus (Torisel®) in Chemotherapy-naïve Castration-Resistant Prostate Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Single Agent Temsirolimus (Torisel®) in Chemotherapy-naïve Castration-Resistant Prostate Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00919035).
- Single and Multiple Ascending Dose Study of AMG 133 in Participants With Obesity: Complete Statistical AnalysisIndependent statistical analysis of Single and Multiple Ascending Dose Study of AMG 133 in Participants With Obesity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Single and Multiple Ascending Dose Study of MTR-601 in Healthy Individuals: Complete Statistical AnalysisIndependent statistical analysis of Single and Multiple Ascending Dose Study of MTR-601 in Healthy Individuals: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Single Dose ADME Study of [14C]-Rencofilstat in Healthy Male Subjects: Complete Statistical AnalysisIndependent statistical analysis of Single Dose ADME Study of [14C]-Rencofilstat in Healthy Male Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05737433).
- Single Dose Intranasal Oxytocin and Cognitive Effects in Autism: Complete Statistical AnalysisIndependent statistical analysis of Single Dose Intranasal Oxytocin and Cognitive Effects in Autism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02493426).
- Single Dose PK of IV Tedizolid Phosphate in Morbidly Obese and Non-Obese Adults: Complete Statistical AnalysisIndependent statistical analysis of Single Dose PK of IV Tedizolid Phosphate in Morbidly Obese and Non-Obese Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Single Dose Study of the Effect of Formoterol Fumarate in Combination With Mometasone Furoate Inhaled Via a Pressurized Metered Dose Inhaler (pMDI) in Children Aged 5-11 Years Old With Persistent Asthma: Complete Statistical AnalysisIndependent statistical analysis of Single Dose Study of the Effect of Formoterol Fumarate in Combination With Mometasone Furoate Inhaled Via a Pressurized Metered Dose Inhaler (pMDI) in Children Aged 5-11 Years Old…
- Single Dose Study to Assess Efficacy and Safety of 4 Doses of LAS100977 in Chronic Obstructive Pulmonary Disease (COPD) Population: Complete Statistical AnalysisIndependent statistical analysis of Single Dose Study to Assess Efficacy and Safety of 4 Doses of LAS100977 in Chronic Obstructive Pulmonary Disease (COPD) Population: primary endpoint results, effect estimate with confidence interval,…
- Single Dose vs. Two Dose Regimen of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections: Complete Statistical AnalysisIndependent statistical analysis of Single Dose vs. Two Dose Regimen of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections: primary endpoint results, effect estimate with confidence interval, sample-size…
- Single Doses of MK-0941 in Type 2 Diabetics (MK-0941-027): Complete Statistical AnalysisIndependent statistical analysis of Single Doses of MK-0941 in Type 2 Diabetics (MK-0941-027): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01106287).
- Single Fraction High-Gradient Partial Breast Irradiation in Treating Patients With Low-Risk Stage 0-I Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Single Fraction High-Gradient Partial Breast Irradiation in Treating Patients With Low-Risk Stage 0-I Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Single Hormone Closed Loop Study With PDT Sensor: Complete Statistical AnalysisIndependent statistical analysis of Single Hormone Closed Loop Study With PDT Sensor: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03528174).
- Single Rising Dose Trial of BI 425809 for Healthy Japanese and Chinese Male Subjects: Complete Statistical AnalysisIndependent statistical analysis of Single Rising Dose Trial of BI 425809 for Healthy Japanese and Chinese Male Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Single-cell CBD Biomarkers of Inflammation Reduction in People Living With HIV: Complete Statistical AnalysisIndependent statistical analysis of Single-cell CBD Biomarkers of Inflammation Reduction in People Living With HIV: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Single-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 827: Complete Statistical AnalysisIndependent statistical analysis of Single-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 827: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Sintilimab in Combination With Gemcitabine and Platinum-Based Chemotherapy as First-Line Therapy for Advanced or Metastatic Squamous NSCLC: Complete Statistical AnalysisIndependent statistical analysis of Sintilimab in Combination With Gemcitabine and Platinum-Based Chemotherapy as First-Line Therapy for Advanced or Metastatic Squamous NSCLC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- SINUS-52Independent statistical analysis of Controlled Clinical Study of Dupilumab in Patients With Nasal Polyps: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02898454).
- SIPIIndependent statistical analysis of Satisfaction of Limited English-Proficient Patients With Phone Interpretation Services Compared to In-Person Interpreters: A Randomized Controlled Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- sipITIndependent statistical analysis of Feasibility of Using sipIT Tools to Increase Compliance With Fluid Consumption Guidelines in Urolithiasis-Prone Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- SIPPYIndependent statistical analysis of Study to Investigate the Potential of Probiotics in Yogurt: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00492583).
- SirolimusIndependent statistical analysis of Pharmacokinetics of Sirolimus and Tacrolimus in Liver Transplant Recipients With Tacrolimus Toxicity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Sirolimus as Secondary Therapy in Chronic Graft-Versus-Host Disease Not Responding To Prior Treatment: Complete Statistical AnalysisIndependent statistical analysis of Sirolimus as Secondary Therapy in Chronic Graft-Versus-Host Disease Not Responding To Prior Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Sirolimus as Treatment of Steroid-Refractory or Steroid-Dependent Chronic Graft-Versus-Host Disease: Complete Statistical AnalysisIndependent statistical analysis of Sirolimus as Treatment of Steroid-Refractory or Steroid-Dependent Chronic Graft-Versus-Host Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00388362).
- Sirolimus to Treat Cowden Syndrome and Other PTEN Hamartomatous Tumor Syndromes: Complete Statistical AnalysisIndependent statistical analysis of Sirolimus to Treat Cowden Syndrome and Other PTEN Hamartomatous Tumor Syndromes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Sirolimus Versus Anti-Vascular Endothelial Growth Factor (antiVEGF) for Wet AMD: Complete Statistical AnalysisIndependent statistical analysis of Sirolimus Versus Anti-Vascular Endothelial Growth Factor (antiVEGF) for Wet AMD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02357342).
- SIRTAIndependent statistical analysis of A Study of the Current Medical Practice and Outcomes in the Treatment of Type 2 Diabetes Mellitus in an Office Setting (MK-0431-199): primary endpoint results, effect estimate with…